Quick Takeaways
- Vivo Opportunity Fund Holdings, L.P. filed SCHEDULE 13G/A for Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (TERN).
- Disclosed ownership: 2.5%.
- Date of event: 31 Jan 2025.
Quoteable Key Fact
"Vivo Opportunity Fund Holdings, L.P. disclosed 2.5% ownership in Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (TERN) on 31 Jan 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Vivo Capital Fund VIII, L.P. | 0.9% | 966,461 | 966,461 | 0 | /s/ Frank Kung | Frank Kung/Managing Member of Vivo Capital VIII, LLC, General Partner | |
| Vivo Capital Surplus Fund VIII, L.P. | 0.1% | 133,415 | 133,415 | 0 | /s/ Frank Kung | Frank Kung/Managing Member of Vivo Capital VIII, LLC, General Partner | |
| Vivo Capital VIII, LLC | 1% | 1,099,876 | 1,099,876 | 0 | /s/ Frank Kung | Frank Kung/Managing Member | |
| Vivo Opportunity Fund Holdings, L.P. | 2.5% | 2,700,615 | 2,700,615 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner | |
| Vivo Opportunity, LLC | 2.5% | 2,700,615 | 2,700,615 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member | |
| Vivo Opportunity Cayman Fund, L.P. | 0.2% | 241,652 | 241,652 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner | |
| Vivo Opportunity Cayman, LLC | 0.2% | 241,652 | 241,652 | 0 | /s/ Kevin Dai | Kevin Dai/Managing Member |